ArticleInflammatory intestinal diseases2021

Serum PR3-ANCA Is a Predictor of Primary Nonresponse to Anti-TNF-α Agents in Patients with Ulcerative Colitis.

Atsushi Yoshida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.